JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

A

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

23 apr. 2026, 00:00 UTC

Evenimente importante

Australian Flash PMI Bounce in April Conceals Deeper Worries

22 apr. 2026, 23:33 UTC

Câștiguri

SK Hynix Posts Record Quarterly Results Amid AI Boom

22 apr. 2026, 22:40 UTC

Câștiguri

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22 apr. 2026, 22:10 UTC

Achiziții, Fuziuni, Preluări

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22 apr. 2026, 21:11 UTC

Câștiguri

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22 apr. 2026, 21:01 UTC

Câștiguri

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22 apr. 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

22 apr. 2026, 23:46 UTC

Market Talk

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22 apr. 2026, 23:34 UTC

Market Talk
Evenimente importante

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22 apr. 2026, 23:16 UTC

Câștiguri

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22 apr. 2026, 23:15 UTC

Câștiguri

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22 apr. 2026, 22:54 UTC

Câștiguri

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22 apr. 2026, 22:54 UTC

Câștiguri

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22 apr. 2026, 22:52 UTC

Câștiguri

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22 apr. 2026, 22:51 UTC

Câștiguri

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22 apr. 2026, 22:31 UTC

Câștiguri

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22 apr. 2026, 22:31 UTC

Câștiguri

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22 apr. 2026, 22:30 UTC

Câștiguri

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22 apr. 2026, 22:30 UTC

Câștiguri

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22 apr. 2026, 22:29 UTC

Câștiguri

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22 apr. 2026, 22:28 UTC

Câștiguri

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22 apr. 2026, 22:28 UTC

Câștiguri

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22 apr. 2026, 22:27 UTC

Câștiguri

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22 apr. 2026, 22:06 UTC

Market Talk
Câștiguri

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22 apr. 2026, 21:55 UTC

Achiziții, Fuziuni, Preluări

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22 apr. 2026, 21:47 UTC

Câștiguri

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 apr. 2026, 21:37 UTC

Câștiguri

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22 apr. 2026, 21:34 UTC

Câștiguri

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22 apr. 2026, 21:29 UTC

Câștiguri

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22 apr. 2026, 21:20 UTC

Market Talk
Câștiguri

Tesla Expands Manufacturing to Chips -- Market Talk

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat